{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:27:01Z","timestamp":1778225221880,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FEDER-PID 2019-106230RB-I00"],"award-info":[{"award-number":["FEDER-PID 2019-106230RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FEDER-PID 2019-106230RB-I00"],"award-info":[{"award-number":["FEDER-PID 2019-106230RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"crossref","award":["FPU16\/04114"],"award-info":[{"award-number":["FPU16\/04114"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RETICS-FEDER RD16\/0008\/0016"],"award-info":[{"award-number":["RETICS-FEDER RD16\/0008\/0016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FARPE-FUNDALUCE"},{"DOI":"10.13039\/501100016386","name":"Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana","doi-asserted-by":"publisher","award":["IDIFEDER\/2017\/064"],"award-info":[{"award-number":["IDIFEDER\/2017\/064"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016386","name":"Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2021\/024"],"award-info":[{"award-number":["PROMETEO\/2021\/024"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016386","name":"Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2021\/024"],"award-info":[{"award-number":["PROMETEO\/2021\/024"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016386","name":"Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana","doi-asserted-by":"publisher","award":["APOSTD\/2020\/245"],"award-info":[{"award-number":["APOSTD\/2020\/245"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Es Retina Asturias","award":["2019\/00286\/001"],"award-info":[{"award-number":["2019\/00286\/001"]}]},{"name":"Es Retina Asturias","award":["2019\/00286\/001"],"award-info":[{"award-number":["2019\/00286\/001"]}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The main clinical symptoms characteristic of Parkinson\u2019s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Human eyes from control (<jats:italic>n<\/jats:italic>\u2009=\u200910) and PD (<jats:italic>n<\/jats:italic>\u2009=\u20099) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40035-023-00348-y","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T12:27:10Z","timestamp":1680524830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson\u2019s disease patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Xavier","family":"S\u00e1nchez-S\u00e1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ortu\u00f1o-Lizar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"S\u00e1nchez-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6767-5710","authenticated-orcid":false,"given":"Nicol\u00e1s","family":"Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"issue":"Pt 5","key":"348_CR1","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinson\u2019s disease. Brain. 2009;132(Pt 5):1128\u201345.","journal-title":"Brain"},{"issue":"6","key":"348_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/mds.22868","volume":"25","author":"KR Chaudhuri","year":"2010","unstructured":"Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The nondeclaration of nonmotor symptoms of Parkinson\u2019s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704\u20139.","journal-title":"Mov Disord"},{"issue":"11","key":"348_CR3","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, et al. Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22(11):1623\u20139.","journal-title":"Mov Disord"},{"issue":"3","key":"348_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mds.870070308","volume":"7","author":"RD Jones","year":"1992","unstructured":"Jones RD, Donaldson IM, Timmings PL. Impairment of high-contrast visual acuity in Parkinson\u2019s disease. Mov Disord. 1992;7(3):232\u20138.","journal-title":"Mov Disord"},{"issue":"7","key":"348_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.47.7.673","volume":"47","author":"D Regan","year":"1984","unstructured":"Regan D, Neima D. Visual fatigue and visual evoked potentials in multiple sclerosis, glaucoma, ocular hypertension and Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1984;47(7):673\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 6","key":"348_CR6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/brain\/110.6.1675","volume":"110","author":"I Bodis-Wollner","year":"1987","unstructured":"Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson\u2019s disease. Loss in spatiotemporal contrast sensitivity. Brain. 1987;110(Pt 6):1675\u201398.","journal-title":"Brain"},{"issue":"21","key":"348_CR7","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/S0042-6989(97)00402-1","volume":"38","author":"BC Regan","year":"1998","unstructured":"Regan BC, Freudenthaler N, Kolle R, Mollon JD, Paulus W. Colour discrimination thresholds in Parkinson\u2019s disease: results obtained with a rapid computer-controlled colour vision test. Vision Res. 1998;38(21):3427\u201331.","journal-title":"Vision Res"},{"issue":"Pt 3","key":"348_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/118.3.771","volume":"118","author":"BA Haug","year":"1995","unstructured":"Haug BA, Kolle RU, Trenkwalder C, Oertel WH, Paulus W. Predominant affection of the blue cone pathway in Parkinson\u2019s disease. Brain. 1995;118(Pt 3):771\u20138.","journal-title":"Brain"},{"issue":"4","key":"348_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00006324-199404000-00002","volume":"71","author":"GL Trick","year":"1994","unstructured":"Trick GL, Kaskie B, Steinman SB. Visual impairment in Parkinson\u2019s disease: deficits in orientation and motion discrimination. Optom Vis Sci. 1994;71(4):242\u20135.","journal-title":"Optom Vis Sci"},{"issue":"12","key":"348_CR10","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1212\/01.wnl.0000191565.11065.11","volume":"65","author":"EY Uc","year":"2005","unstructured":"Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology. 2005;65(12):1907\u201313.","journal-title":"Neurology"},{"key":"348_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuropsychologia.2015.11.019","volume":"80","author":"CA Wang","year":"2016","unstructured":"Wang CA, McInnis H, Brien DC, Pari G, Munoz DP. Disruption of pupil size modulation correlates with voluntary motor preparation deficits in Parkinson\u2019s disease. Neuropsychologia. 2016;80:176\u201384.","journal-title":"Neuropsychologia"},{"issue":"1","key":"348_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/JPD-191830","volume":"11","author":"R Netser","year":"2021","unstructured":"Netser R, Demmin DL, Dobkin R, Goldstein A, Roche M, Netser Zernik A, et al. Flash electroretinography parameters and Parkinson\u2019s disease. J Parkinsons Dis. 2021;11(1):251\u20139.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"348_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0168-5597(95)00169-7","volume":"100","author":"M Tagliati","year":"1996","unstructured":"Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson\u2019s disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol. 1996;100(1):1\u201311.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"348_CR14","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.preteyeres.2020.100938","volume":"83","author":"AH Kashani","year":"2021","unstructured":"Kashani AH, Asanad S, Chan JW, Singer MB, Zhang J, Sharifi M, et al. Past, present and future role of retinal imaging in neurodegenerative disease. Prog Retin Eye Res. 2021;83:100938.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"348_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.25897","volume":"88","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2020","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Sanchez-Saez X, Lax P, Serrano GE, Beach TG, Adler CH, et al. Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease. Ann Neurol. 2020;88(5):893\u2013906.","journal-title":"Ann Neurol"},{"issue":"1","key":"348_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","volume":"6","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, et al. Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson\u2019s disease. Acta Neuropathol Commun. 2018;6(1):90.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"348_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N. Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov Disord. 2018;33(8):1315\u201324.","journal-title":"Mov Disord"},{"issue":"6","key":"348_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. alpha-synuclein in the inner retina in Parkinson disease. Ann Neurol. 2014;75(6):964\u20136.","journal-title":"Ann Neurol"},{"key":"348_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-neuro-072116-031335","volume":"40","author":"AS Mauss","year":"2017","unstructured":"Mauss AS, Vlasits A, Borst A, Feller M. Visual circuits for direction selectivity. Annu Rev Neurosci. 2017;40:211\u201330.","journal-title":"Annu Rev Neurosci"},{"issue":"6900","key":"348_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nature00931","volume":"418","author":"T Euler","year":"2002","unstructured":"Euler T, Detwiler PB, Denk W. Directionally selective calcium signals in dendrites of starburst amacrine cells. Nature. 2002;418(6900):845\u201352.","journal-title":"Nature"},{"issue":"3","key":"348_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0896-6273(01)00316-6","volume":"30","author":"K Yoshida","year":"2001","unstructured":"Yoshida K, Watanabe D, Ishikane H, Tachibana M, Pastan I, Nakanishi S. A key role of starburst amacrine cells in originating retinal directional selectivity and optokinetic eye movement. Neuron. 2001;30(3):771\u201380.","journal-title":"Neuron"},{"issue":"1","key":"348_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0006-8993(02)04049-0","volume":"964","author":"N Cuenca","year":"2003","unstructured":"Cuenca N, Deng P, Linberg KA, Fisher SK, Kolb H. Choline acetyltransferase is expressed by non-starburst amacrine cells in the ground squirrel retina. Brain Res. 2003;964(1):21\u201330.","journal-title":"Brain Res"},{"issue":"8","key":"348_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tins.2005.06.002","volume":"28","author":"RH Masland","year":"2005","unstructured":"Masland RH. The many roles of starburst amacrine cells. Trends Neurosci. 2005;28(8):395\u20136.","journal-title":"Trends Neurosci"},{"key":"348_CR24","doi-asserted-by":"publisher","first-page":"E009","DOI":"10.1017\/S0952523819000087","volume":"36","author":"AJ Chandra","year":"2019","unstructured":"Chandra AJ, Lee SCS, Grunert U. Melanopsin and calbindin immunoreactivity in the inner retina of humans and marmosets. Vis Neurosci. 2019;36:E009.","journal-title":"Vis Neurosci"},{"issue":"1","key":"348_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/cne.903210106","volume":"321","author":"RW Rodieck","year":"1992","unstructured":"Rodieck RW, Marshak DW. Spatial density and distribution of choline acetyltransferase immunoreactive cells in human, macaque, and baboon retinas. J Comp Neurol. 1992;321(1):46\u201364.","journal-title":"J Comp Neurol"},{"issue":"1","key":"348_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cne.902850104","volume":"285","author":"RW Rodieck","year":"1989","unstructured":"Rodieck RW. Starburst amacrine cells of the primate retina. J Comp Neurol. 1989;285(1):18\u201337.","journal-title":"J Comp Neurol"},{"issue":"11","key":"348_CR27","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/0042-6989(92)90063-O","volume":"32","author":"GD Guiloff","year":"1992","unstructured":"Guiloff GD, Kolb H. Neurons immunoreactive to choline acetyltransferase in the turtle retina. Vision Res. 1992;32(11):2023\u201330.","journal-title":"Vision Res"},{"key":"348_CR28","unstructured":"Kolb H. Roles of Amacrine Cells. 2005 May 1 [Updated 2007 Apr 30]. In: Kolb H, Fernandez E, Nelson R, editors. Webvision: The Organization of the Retina and Visual System [Internet]. Salt Lake City (UT): University of Utah Health Sciences Center; 1995. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK11539\/."},{"key":"348_CR29","unstructured":"Ram\u00f3n y Cajal SR. La Retina de los Vertebrados. Edited from La R\u00e9tine des Vert\u00e9br\u00e9s (1892) by Nicol\u00e1s Cuenca and Pedro de la Villa: Consejo Superior de Investigaciones Cientificas (CSIC), Madrid (2021)."},{"issue":"4","key":"348_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/neup.12189","volume":"35","author":"TG Beach","year":"2015","unstructured":"Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, et al. Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology. 2015;35(4):354\u201389.","journal-title":"Neuropathology"},{"issue":"6","key":"348_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.devcel.2022.02.018","volume":"57","author":"ED Thomas","year":"2021","unstructured":"Thomas ED, Timms AE, Giles S, Harkins-Perry S, Lyu P, Hoang T, et al. Cell-specific cis-regulatory elements and mechanisms of non-coding genetic disease in human retina and retinal organoids. Dev Cell. 2021;57(6):820\u201336.","journal-title":"Dev Cell"},{"issue":"13","key":"348_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u201387.","journal-title":"Cell"},{"key":"348_CR33","doi-asserted-by":"publisher","first-page":"100844","DOI":"10.1016\/j.preteyeres.2020.100844","volume":"78","author":"U Grunert","year":"2020","unstructured":"Grunert U, Martin PR. Cell types and cell circuits in human and non-human primate retina. Prog Retin Eye Res. 2020;78:100844.","journal-title":"Prog Retin Eye Res"},{"key":"348_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jchemneu.2016.11.003","volume":"83\u201384","author":"RA Cliburn","year":"2017","unstructured":"Cliburn RA, Dunn AR, Stout KA, Hoffman CA, Lohr KM, Bernstein AI, et al. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain. J Chem Neuroanat. 2017;83\u201384:82\u201390.","journal-title":"J Chem Neuroanat"},{"issue":"17","key":"348_CR35","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1523\/JNEUROSCI.5436-03.2004","volume":"24","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P, Veisenberger E, Haycock JW, Akopian A, Garcia-Espana A, Meller E. Activity-dependent phosphorylation of tyrosine hydroxylase in dopaminergic neurons of the rat retina. J Neurosci. 2004;24(17):4242\u20139.","journal-title":"J Neurosci"},{"issue":"11","key":"348_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","volume":"5","author":"P Calabresi","year":"2006","unstructured":"Calabresi P, Picconi B, Parnetti L, Di Filippo M. A convergent model for cognitive dysfunctions in Parkinson\u2019s disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol. 2006;5(11):974\u201383.","journal-title":"Lancet Neurol"},{"issue":"2","key":"348_CR37","doi-asserted-by":"publisher","first-page":"fcab109","DOI":"10.1093\/braincomms\/fcab109","volume":"3","author":"NI Bohnen","year":"2021","unstructured":"Bohnen NI, Kanel P, Koeppe RA, Sanchez-Catasus CA, Frey KA, Scott P, et al. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson\u2019s disease. Brain Commun. 2021;3(2):fcab109.","journal-title":"Brain Commun"},{"issue":"12","key":"348_CR38","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1523\/JNEUROSCI.07-12-04115.1987","volume":"7","author":"T Voigt","year":"1987","unstructured":"Voigt T, Wassle H. Dopaminergic innervation of A II amacrine cells in mammalian retina. J Neurosci. 1987;7(12):4115\u201328.","journal-title":"J Neurosci"},{"issue":"2","key":"348_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/cne.903100210","volume":"310","author":"H Kolb","year":"1991","unstructured":"Kolb H, Cuenca N, Dekorver L. Postembedding immunocytochemistry for GABA and glycine reveals the synaptic relationships of the dopaminergic amacrine cell of the cat retina. J Comp Neurol. 1991;310(2):267\u201384.","journal-title":"J Comp Neurol"},{"issue":"3","key":"348_CR40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jnc.13144","volume":"134","author":"G Debertin","year":"2015","unstructured":"Debertin G, Kantor O, Kovacs-Oller T, Balogh L, Szabo-Meleg E, Orban J, et al. Tyrosine hydroxylase positive perisomatic rings are formed around various amacrine cell types in the mammalian retina. J Neurochem. 2015;134(3):416\u201328.","journal-title":"J Neurochem"},{"issue":"9","key":"348_CR41","doi-asserted-by":"publisher","first-page":"e74439","DOI":"10.1371\/journal.pone.0074439","volume":"8","author":"L Campello","year":"2013","unstructured":"Campello L, Esteve-Rudd J, Bru-Martinez R, Herrero MT, Fernandez-Villalba E, Cuenca N, et al. Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys. PLoS ONE. 2013;8(9):e74439.","journal-title":"PLoS ONE"},{"issue":"2","key":"348_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cne.20761","volume":"493","author":"N Cuenca","year":"2005","unstructured":"Cuenca N, Herrero MT, Angulo A, de Juan E, Martinez-Navarrete GC, Lopez S, et al. Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson\u2019s disease. J Comp Neurol. 2005;493(2):261\u201373.","journal-title":"J Comp Neurol"},{"issue":"1","key":"348_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2011.06.009","volume":"44","author":"J Esteve-Rudd","year":"2011","unstructured":"Esteve-Rudd J, Fernandez-Sanchez L, Lax P, De Juan E, Martin-Nieto J, Cuenca N. Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina. Neurobiol Dis. 2011;44(1):102\u201315.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"348_CR44","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1038\/s41598-020-66497-6","volume":"10","author":"E Marrocco","year":"2020","unstructured":"Marrocco E, Indrieri A, Esposito F, Tarallo V, Carboncino A, Alvino FG, et al. alpha-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells. Sci Rep. 2020;10(1):9619.","journal-title":"Sci Rep"},{"issue":"3","key":"348_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","volume":"137","author":"L Veys","year":"2019","unstructured":"Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L, et al. Retinal alpha-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathol. 2019;137(3):379\u201395.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"348_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tins.2011.08.002","volume":"34","author":"W Wei","year":"2011","unstructured":"Wei W, Feller MB. Organization and development of direction-selective circuits in the retina. Trends Neurosci. 2011;34(12):638\u201345.","journal-title":"Trends Neurosci"},{"key":"348_CR47","unstructured":"Liu J. The Anatomy and Physiology of Direction-Selective Retinal Ganglion Cells. 2015 Aug 20. In: Kolb H, Fernandez E, Nelson R, editors. Webvision: The Organization of the Retina and Visual System [Internet]. Salt Lake City (UT): University of Utah Health Sciences Center; 1995. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK321299\/."},{"issue":"3764","key":"348_CR48","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.155.3764.841","volume":"155","author":"CW Oyster","year":"1979","unstructured":"Oyster CW, Barlow HB. Direction-selective units in rabbit retina: distribution of preferred directions. Science. 1979;155(3764):841\u20132.","journal-title":"Science"},{"issue":"7186","key":"348_CR49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature06739","volume":"452","author":"IJ Kim","year":"2008","unstructured":"Kim IJ, Zhang Y, Yamagata M, Meister M, Sanes JR. Molecular identification of a retinal cell type that responds to upward motion. Nature. 2008;452(7186):478\u201382.","journal-title":"Nature"},{"issue":"7659","key":"348_CR50","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature22818","volume":"546","author":"S Sabbah","year":"2017","unstructured":"Sabbah S, Gemmer JA, Bhatia-Lin A, Manoff G, Castro G, Siegel JK, et al. A retinal code for motion along the gravitational and body axes. Nature. 2017;546(7659):492\u20137.","journal-title":"Nature"},{"issue":"1","key":"348_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1523\/JNEUROSCI.1784-18.2018","volume":"39","author":"OS Dhande","year":"2019","unstructured":"Dhande OS, Stafford BK, Franke K, El-Danaf R, Percival KA, Phan AH, et al. Molecular fingerprinting of On\u2013Off direction-selective retinal ganglion cells across species and relevance to primate visual circuits. J Neurosci. 2019;39(1):78\u201395.","journal-title":"J Neurosci"},{"issue":"1","key":"348_CR52","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1038\/s41467-022-30405-5","volume":"13","author":"YJ Kim","year":"2022","unstructured":"Kim YJ, Peterson BB, Crook JD, Joo HR, Wu J, Puller C, et al. Origins of direction selectivity in the primate retina. Nat Commun. 2022;13(1):2862.","journal-title":"Nat Commun"},{"issue":"1","key":"348_CR53","doi-asserted-by":"publisher","first-page":"e54667","DOI":"10.1371\/journal.pone.0054667","volume":"8","author":"S Moritoh","year":"2013","unstructured":"Moritoh S, Komatsu Y, Yamamori T, Koizumi A. Diversity of retinal ganglion cells identified by transient GFP transfection in organotypic tissue culture of adult marmoset monkey retina. PLoS ONE. 2013;8(1):e54667.","journal-title":"PLoS ONE"},{"issue":"3","key":"348_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrn3165","volume":"13","author":"DI Vaney","year":"2012","unstructured":"Vaney DI, Sivyer B, Taylor WR. Direction selectivity in the retina: symmetry and asymmetry in structure and function. Nat Rev Neurosci. 2012;13(3):194\u2013208.","journal-title":"Nat Rev Neurosci"},{"key":"348_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2022.06.018","volume":"101","author":"LGM Mello","year":"2022","unstructured":"Mello LGM, Paraguay IBB, Andrade TS, Rocha A, Barbosa ER, Oyamada MK, et al. Electroretinography reveals retinal dysfunction in Parkinson\u2019s disease despite normal high-resolution optical coherence tomography findings. Parkinsonism Relat Disord. 2022;101:90\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"348_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"JY Lee","year":"2022","unstructured":"Lee JY, Martin-Bastida A, Murueta-Goyena A, Gabilondo I, Cuenca N, Piccini P, et al. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat Rev Neurol. 2022;18(4):203\u201320.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"348_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","volume":"127","author":"ME Hajee","year":"2009","unstructured":"Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009;127(6):737\u201341.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"348_CR58","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajo.2013.09.028","volume":"157","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, et al. Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol. 2014;157(2):470-8.e2.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"348_CR59","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1212\/WNL.0000000000006157","volume":"91","author":"J Ahn","year":"2018","unstructured":"Ahn J, Lee JY, Kim TW, Yoon EJ, Oh S, Kim YK, et al. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology. 2018;91(11):e1003\u201312.","journal-title":"Neurology"},{"key":"348_CR60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","volume":"64","author":"A Chrysou","year":"2019","unstructured":"Chrysou A, Jansonius NM, van Laar T. Retinal layers in Parkinson\u2019s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord. 2019;64:40\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"348_CR61","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1038\/s41598-019-48388-7","volume":"9","author":"MS Sung","year":"2019","unstructured":"Sung MS, Choi SM, Kim J, Ha JY, Kim BC, Heo H, et al. Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson\u2019s disease. Sci Rep. 2019;9(1):11832.","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1186\/s40035-023-00360-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000}}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00348-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:43:34Z","timestamp":1683708214000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00348-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s40035-023-00360-2","asserted-by":"object"}]},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40035-023-00360-2","URL":"https:\/\/doi.org\/10.1186\/s40035-023-00360-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects involved in the study signed informed written consent. Procedures involving human participants and data were approved by the ethics committee of the University of Alicante (UA-2018-04-17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}